351 related articles for article (PubMed ID: 29397310)
1. Characteristics of Symptomatic Intracerebral Hemorrhage in Patient Receiving Direct Oral Anticoagulants: Comparison with Warfarin.
Kawabori M; Niiya Y; Iwasaki M; Mabuchi S; Ozaki H; Matsubara K; Houkin K
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1338-1342. PubMed ID: 29397310
[TBL] [Abstract][Full Text] [Related]
2. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants].
Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T
Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
Okishige K; Nakamura T; Aoyagi H; Kawaguchi N; Yamashita M; Kurabayashi M; Suzuki H; Asano M; Shimura T; Yamauchi Y; Sasano T; Hirao K
J Cardiol; 2017 Jan; 69(1):11-15. PubMed ID: 27160710
[TBL] [Abstract][Full Text] [Related]
6. New Oral Anticoagulants: What Prescribers Should Know; Differences and Similarities between Warfarin and "New Agents" (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) - Review of Indications, Contraindications and Safety of Use.
Petrasko M; Raizada A; Petraskova T
S D Med; 2016 Aug; 69(8):363-369. PubMed ID: 28806005
[No Abstract] [Full Text] [Related]
7. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Coleman CI; Peacock WF; Bunz TJ; Alberts MJ
Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814
[TBL] [Abstract][Full Text] [Related]
8. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED
Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497
[TBL] [Abstract][Full Text] [Related]
9. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups.
Lip GY; Mitchell SA; Liu X; Liu LZ; Phatak H; Kachroo S; Batson S
Int J Cardiol; 2016 Feb; 204():88-94. PubMed ID: 26655548
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants.
Wolfe Z; Khan SU; Nasir F; Raghu Subramanian C; Lash B
J Thromb Haemost; 2018 Jul; 16(7):1296-1306. PubMed ID: 29723935
[TBL] [Abstract][Full Text] [Related]
11. Severity of Gastrointestinal Bleeding in Patients Treated with Direct-Acting Oral Anticoagulants.
Brodie MM; Newman JC; Smith T; Rockey DC
Am J Med; 2018 May; 131(5):573.e9-573.e15. PubMed ID: 29175237
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists.
Shin SS; Marsh EB; Ali H; Nyquist PA; Hanley DF; Ziai WC
Neurocrit Care; 2020 Apr; 32(2):407-418. PubMed ID: 32034657
[TBL] [Abstract][Full Text] [Related]
13. An update on the bleeding risks associated with DOACs.
Drug Ther Bull; 2017 Nov; 55(11):129-132. PubMed ID: 29117993
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements.
Pasciolla S; Zizza LF; Le T; Wright K
Clin Drug Investig; 2020 Sep; 40(9):839-845. PubMed ID: 32607688
[TBL] [Abstract][Full Text] [Related]
15. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.
Eikelboom J; Merli G
Am J Med; 2016 Nov; 129(11S):S33-S40. PubMed ID: 27586367
[TBL] [Abstract][Full Text] [Related]
16. Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients.
Woo HG; Chung I; Gwak DS; Kim BK; Kang JH; Kim BJ; Bae HJ; Han MK
J Clin Neurosci; 2019 Mar; 61():160-165. PubMed ID: 30587420
[TBL] [Abstract][Full Text] [Related]
17. Bleeding with direct oral anticoagulants vs warfarin: clinical experience.
Eikelboom J; Merli G
Am J Emerg Med; 2016 Nov; 34(11S):3-8. PubMed ID: 27697439
[TBL] [Abstract][Full Text] [Related]
18. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials.
Loffredo L; Perri L; Violi F
Dig Liver Dis; 2015 May; 47(5):429-31. PubMed ID: 25732432
[TBL] [Abstract][Full Text] [Related]
19. Jurisdictional Guidance on DOAC Use-Will It Affect Practice? A Comparison of European, American, and Canadian Product Monographs.
Lamb DA; Bungard TJ; Lowerison J; Semchuk WM; Thomson P; Brocklebank C; Bolt J
Ann Pharmacother; 2020 Mar; 54(3):277-282. PubMed ID: 31529984
[No Abstract] [Full Text] [Related]
20. A comparison between vitamin K antagonists and new oral anticoagulants.
Jolobe OMP
Br J Clin Pharmacol; 2017 Nov; 83(11):2589-2590. PubMed ID: 28703392
[No Abstract] [Full Text] [Related]
[Next] [New Search]
